ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Rheumatology

Top Rheumatology Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FARRUKH ANWAR MD

Rheumatology

12,117

$717K

426
266 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

35%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $171

IMAD ALAZEM M.D.

Rheumatology

10,978

$492K

333
262 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $171

TIMOTHY SWARTZ M.D.

Rheumatology

7,716

$1.02M

606
391 are 65+

21%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$132
Average prescription price

Avg: $171

DAVID VALLANCE M.D.

Rheumatology

7,231

$879K

290
165 are 65+

27%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $171

ROBERT HYLLAND M.D.

Rheumatology

5,819

$1.36M

600
480 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$233
Average prescription price

Avg: $171

NITI THAKUR MD

Rheumatology

5,512

$861K

405
205 are 65+

20%
patients receiving schedule two controlled substances

Avg: 2%

44%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$156
Average prescription price

Avg: $171

HARRIS WEAVER MD

Rheumatology

4,982

$938K

381
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$188
Average prescription price

Avg: $171

LEWIS ROSENBAUM MD

Rheumatology

4,926

$500K

236
215 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$101
Average prescription price

Avg: $171

JOHN KOLSTOE MD

Rheumatology

4,724

$316K

192
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $171

ANITA KIRSCH MD

Rheumatology

4,207

$349K

283
190 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $171

CHARLES HUEBNER MD

Rheumatology

4,154

$1.16M

536
405 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$280
Average prescription price

Avg: $171

VIOLETTE HENEIN M.D.

Rheumatology

4,084

$462K

467
337 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$113
Average prescription price

Avg: $171

MARTIN PEVZNER M.D,

Rheumatology

4,018

$962K

413
331 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$239
Average prescription price

Avg: $171

BARBARA MCINTOSH-MOORE MD

Rheumatology

3,994

$744K

371
214 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$186
Average prescription price

Avg: $171

CARLOS DIOLA M.D.

Rheumatology

3,856

$810K

509
317 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$210
Average prescription price

Avg: $171

ANTHONY BARON MD

Rheumatology

3,817

$316K

296
249 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $171

JUSTUS FIECHTNER M.D.,M.P.H.

Rheumatology

3,592

$628K

484
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$175
Average prescription price

Avg: $171

CAROL BEALS MD

Rheumatology

3,555

$545K

404
291 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$153
Average prescription price

Avg: $171

SURAYYA SOARES M.D.

Rheumatology

3,497

$241K

271
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $171

HENRY BRYSTOWSKI M.D.

Rheumatology

3,452

$496K

347
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$144
Average prescription price

Avg: $171

SANJEEV PRAKASH M.D

Rheumatology

3,426

$752K

349
241 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$220
Average prescription price

Avg: $171

DONARD HAGGINS M.D.

Rheumatology

3,405

$422K

372
244 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$124
Average prescription price

Avg: $171

PARVEEN QAZI M.D.

Rheumatology

3,382

$673K

389
244 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$199
Average prescription price

Avg: $171

ANDREW HEAD M.D.

Rheumatology

3,292

$447K

358
268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$136
Average prescription price

Avg: $171

ALLAN MORTON D.O.

Rheumatology

3,220

$559K

355
262 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$174
Average prescription price

Avg: $171

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank